Relay Therapeutics Inc. (RLAY) Social Stream
RELAY THERAPEUTICS INC (RLAY) Price Targets From Analysts
Use the tables below to see what analysts covering RELAY THERAPEUTICS INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-10-11 | 5 | $66 | $51 | $57 | $21.68 | 162.92% |
| 2021-11-11 | 5 | $66 | $51 | $56.25 | $21.68 | 159.46% |
| 2021-11-12 | 4 | $54 | $47 | $51.666 | $21.68 | 138.31% |
| 2022-03-03 | 5 | $54 | $45 | $50 | $21.68 | 130.63% |
| 2022-05-06 | 5 | $54 | $45 | $48 | $21.68 | 121.4% |
| 2022-05-10 | 5 | $47 | $35 | $44 | $21.68 | 102.95% |
| 2022-05-24 | 6 | $47 | $35 | $43.666 | $21.68 | 101.41% |
| 2022-06-06 | 7 | $47 | $13 | $39.285 | $21.68 | 81.2% |
| 2022-08-05 | 7 | $47 | $13 | $38 | $21.68 | 75.28% |
| 2022-08-13 | 7 | $47 | $13 | $37.857 | $21.68 | 74.62% |
| 2022-09-02 | 8 | $47 | $13 | $38.125 | $21.68 | 75.85% |
| 2022-09-17 | 9 | $50 | $16 | $39.75 | $21.68 | 83.35% |
| 2022-09-30 | 10 | $50 | $16 | $37.888 | $21.68 | 74.76% |
| 2022-10-07 | 10 | $50 | $16 | $37.666 | $21.68 | 73.74% |
| 2022-11-07 | 10 | $50 | $16 | $37.444 | $21.68 | 72.71% |
| 2022-12-20 | 10 | $45 | $16 | $36.666 | $21.68 | 69.12% |
| 2023-01-27 | 10 | $45 | $16 | $35.555 | $21.68 | 64% |
The Trend in the Analyst Price Target
RLAY's average price target has moved down $20.7 over the prior 15 months.
Over the past 48 weeks, RLAY's average upside potential has been 102.78%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-03 | 5 | 54 | 45 | 50.000 | 22.07 | 126.55% |
| 2022-05-10 | 5 | 47 | 35 | 44.000 | 17.03 | 158.37% |
| 2022-05-24 | 7 | 47 | 35 | 43.666 | 16.65 | 162.26% |
| 2022-09-17 | 9 | 50 | 16 | 39.750 | 23.42 | 69.73% |
| 2022-11-07 | 10 | 45 | 16 | 36.666 | 20.36 | 80.09% |
RLAY Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.5 | 8 | 0 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
Over the past 92 days, RLAY's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RLAY as an investment opportunity.
- RLAY has a lower variance in analysts' estimates than -1156.39% of all US stocks.
- To contextualize these metrics, consider that out of all US stocks, RELAY THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 1768.84% of them.
- To contextualize these metrics, consider that out of stocks in the mid market cap category, RELAY THERAPEUTICS INC's number of analysts covering the stock is higher than 1086.38% of them.
- In terms of how RELAY THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its average analyst price target is greater than 1491.16% of that group.
Stocks similar to RELAY THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are ALVR, KYMR, and CCCC.
View All Top Stocks by Price Target
Is RLAY a Buy, Hold or Sell? See the POWR Ratings now!